A Study of KC1036 Versus Investigator ' s Choice of Chemotherapy in Patients With Advanced Esophageal Cancer
Conditions: Esophageal Squamous Cell Carcinoma Interventions: Drug: KC1036; Drug: Irinotecan; Drug: Docetaxel; Drug: S-1 Sponsors: Beijing Konruns Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Docetaxel | Esophagus Cancer | Research | Skin Cancer | Squamous Cell Carcinoma | Study | Taxotere